![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 10, 2017 11:58:46 AM
One of the leading biotechnology stocks that has been under pressure recently is Biogen Inc (NASDAQ:BIIB). This stock has been selling off since the company reported earnings on April 25th, 2017. On that day, BIIB stock traded as high as $291.90 a share. Since that time, the bio-tech giant has dropped lower by nearly $34.00. Currently, BIIB stock is trading at $258.86 a share.
Traders and investors should note that the charts are signaling institutional support around the $250.00 area. This is a solid whole round number that the institutional traders and investors usually like to play. It is also a level where the stock was defended in the past. Traders should note that this trade level was chart support in late January 2017 and late October 2016. Very often, past support levels will be solid levels for bounces when retested.
![](http://www.inthemoneystocks.com/images/BIIB%205.10.17.png)
Nicholas Santiago
InTheMoneyStocks
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM